Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M606Revenue (TTM) $M188Net Margin (%)6.7Altman Z-Score2.2
Enterprise Value $M702EPS (TTM) $0.3Operating Margin %16.1Piotroski F-Score6
P/E(ttm)50.9Beneish M-Score-1.0Pre-tax Margin (%)6.9Higher ROA y-yN
Price/Book4.910-y EBITDA Growth Rate %--Quick Ratio3.9Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %--Current Ratio4.3Lower Leverage y-yN
Price/Free Cash Flow24.4y-y EBITDA Growth Rate %59.3ROA % (ttm)3.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)11.7Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M45.8ROIC % (ttm)19.4Gross Margin Increase y-yN

Gurus Latest Trades with SCMP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SCMPJoel Greenblatt 2016-06-30 Sold Out -0.03%$10.09 - $12.42
($11.19)
$ 13.2318%Sold Out0
SCMPJoel Greenblatt 2016-03-31 Reduce-0.06%$9.84 - $17.29
($12.7)
$ 13.234%Reduce -51.23%284,704
SCMPJoel Greenblatt 2015-12-31 Add0.08%$15.56 - $21.48
($17.91)
$ 13.23-26%Add 273.69%583,716
SCMPJoel Greenblatt 2015-09-30 Reduce-0.03%$16.34 - $28.96
($22.93)
$ 13.23-42%Reduce -53.28%156,205
SCMPJoel Greenblatt 2015-06-30 Add0.03%$14.5 - $21.75
($17.31)
$ 13.23-24%Add 222.92%334,346
SCMPJoel Greenblatt 2015-03-31 Buy 0.01%$13.12 - $18.56
($15.5)
$ 13.23-15%New holding103,538
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SCMP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SCMP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Smith Andrew PCFO 2015-11-16Buy1,605$17.03-22.31view
Getman Daniel PDirector 2015-08-28Sell30,000$28.14-52.99view
Knapp Thomas JFormer Officer 2015-07-20Sell64,528$23.43-43.53view
Kuno Sachiko10% Owner 2015-03-31Sell1,600,000$14-5.5view
S&R Technology Holdings, LLC10% Owner 2015-03-31Sell1,186,113$14-5.5view
Ueno Ryuji10% Owner 2015-03-31Sell1,600,000$14-5.5view
Ashton WilliamDirector 2015-03-12Sell129,766$17.42-24.05view
Celeste Anthony C.Director 2015-03-11Sell65,966$17.34-23.7view
Claiborne Cary JFormer Chief Financial Officer 2014-12-16Sell50,000$12.912.48view
S&R Technology Holdings, LLC10% Owner 2014-08-07Sell181,727$6.28110.67view

Quarterly/Annual Reports about SCMP:

News about SCMP:

Articles On GuruFocus.com
NeoPhotonics Delivers Sustained Profitability; Gevo Continues Biofuel Deal Momentum May 08 2015 
Pharmaceutical Stock Picks For March Mar 04 2015 
Weekly CEO Sells Highlight: VeriFone Systems Inc, Northeast Utilities, Sucampo Pharmaceuticals Inc, Jan 26 2014 
Weekly CEO Sells Highlight: Sucampo Pharmaceuticals Inc, Family Dollar Stores Inc, Nike Inc, Hallibu Oct 21 2013 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 08 2011 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 03 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) May 10 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 06 2009 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 07 2009 

More From Other Websites
ETF’s with exposure to Sucampo Pharmaceuticals, Inc. : September 23, 2016 Sep 23 2016
Coverage initiated on Sucampo Pharma by Northland Capital Sep 07 2016
Sucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCMP-US :... Sep 07 2016
ETF’s with exposure to Sucampo Pharmaceuticals, Inc. : September 2, 2016 Sep 02 2016
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Aug 26 2016
Sucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCMP-US :... Aug 22 2016
ETF’s with exposure to Sucampo Pharmaceuticals, Inc. : August 15, 2016 Aug 15 2016
SUCAMPO PHARMACEUTICALS, INC. Financials Aug 11 2016
Sucampo Pharmaceuticals, Inc. :SCMP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 Aug 10 2016
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Aug 08 2016
Sucampo Pharmaceuticals, Inc.: Gathering momentum, can it sustain its performance? Aug 04 2016
Edited Transcript of SCMP earnings conference call or presentation 3-Aug-16 12:30pm GMT Aug 03 2016
Sucampo Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today Aug 03 2016
Q2 2016 Sucampo Pharmaceuticals Inc Earnings Release - Before Market Open Aug 03 2016
Sucampo Reports Second Quarter 2016 Financial Results Aug 03 2016
Sucampo reports 2Q loss Aug 03 2016
Sucampo reports 2Q loss Aug 03 2016
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 03 2016
Sucampo Reports Second Quarter 2016 Financial Results Aug 03 2016
Paul Edick Joins Sucampo’s Board of Directors Jul 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)